-
Artificial Intelligence enters the HD space as a diagnostic tool
Latest News
-
We are not alone, and are seeing more RED
Scientists have found more people have the genetic changes that underlie repeat expansion diseases, like HD, than previously thought. This new data tells doctors to consider expansion diseases more when diagnosing people with neurological symptoms.
-
Huntington Study Group (HSG) Conference 2024 – Day 3
Read updates from clinical trials and scientific research on Huntington’s disease from Day 3 of the 2024 Huntington Study Group conference.
-
Huntington Study Group (HSG) Conference 2024 – Day 2
Read updates from clinical trials and scientific research on Huntington’s disease from Day 2 of the 2024 Huntington Study Group conference
-
Huntington Study Group (HSG) Conference 2024 – Day 1
Read updates from clinical trials and scientific research on Huntington’s disease from Day 1 of the 2024 Huntington Study Group conference #HSG2024
-
2024 HDBuzz Prize: Social Skills – The Hidden Gem in Improving Quality of Life for People with Huntington's disease?
We're proud to announce Molly Gracey as a 2024 HDBuzz Prize winner! Could social skills be the secret ingredient to a better quality of life in people with #HuntingtonsDisease? Clues suggest these 'hidden gems' impact #QualityOfLife in HD.
-
2024 HDBuzz Prize: Thinking beyond therapies – it’s time to consider racial disparity in HD care and research
We're proud to announce Dr. Zanna Voysey as a 2024 HDBuzz Prize winner! She shares a new study that details racial disparities in HD care and research. Addressing this could improve the lives of people living with HD in the here-and-now.
-
Announcing the 2024 HDBuzz Prize for Young Science Writers!
The 2024 #HDBuzz Prize for Young #Science Writers opened this summer. We’ll bring you #HuntingtonsDisease #research articles from the winners through the next few months, sharing fresh voices on HDBuzz. (Trophy not included.)
-
Bringing HD Treatments to Market: The Role of Regulatory Oversight
Moving drugs from the lab bench to pharmacy shelves is no small task. In this article we delve into the role regulatory oversight plays in clinical trials and the approval of medicines for Huntington’s disease.
-
Interruptions are encouraged
A CRISPR-based approach called “base editing” is being explored to develop a new potential treatment for Huntington's disease. Editing a single letter in the genetic code with base editing may be the key for delaying HD symptoms, maybe by a decade.
-
HDBuzz needs your help
We’re asking for your donation to ensure the continuity of our services. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community.
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
